問卷

TPIDB > Principal Investigator

Principal Investigator


Taichung Veterans General Hospital (在職)

Division of Urology

更新時間:2023-09-19

王樹吉
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2020-02-28 - 2023-08-04

Phase II

Completed
A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Subjects Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) and FGFR Mutations or Fusions
  • Condition/Disease

    Non-Muscle-Invasive Bladder Cancer (NMIBC)

  • Test Drug

    Erdafitinib Gemcitabine Mitomycin

Participate Sites
6Sites

Not yet recruiting6Sites

2020-03-01 - 2026-12-31

Phase III

Active
An Open-label, Randomized Phase 3 Study of MK-6482 Versus Everolimus in Participants With Advanced Renal Cell Carcinoma That Has Progressed After Prior PD-1/L1 and VEGF-Targeted Therapies
  • Condition/Disease

    Advanced Renal Cell Carcinoma

  • Test Drug

    MK-6482 R/AfinitorR

Participate Sites
6Sites

Not yet recruiting2Sites

Recruiting4Sites